Drugs / MSC_apceth_101
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT02008539 | Oct 2013 → Sep 2016 | digestive system cancer | Apceth GmbH & Co. KG | Terminated | No outcome recorded Stop: Enrollment |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MSC_apceth_101 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02008539 ↗ |
| Modality | Cell therapy | “Modified Autologous MSC_apceth_101” NCT02008539 ↗ |